25 Disease modification in SLE: an introduction

25 Disease modification in SLE: an introduction

Bibliographic Details
Main Author:	Ronald van Vollenhoven
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-09-01
Series:	Lupus Science and Medicine

Similar Items

05 Approved biologics for SLE: which to try first and in which patients? – The case for belimumab
by: Ronald van Vollenhoven
Published: (2023-09-01)

Targeting DORIS Remission and LLDAS in SLE: A Review
by: Agner R. Parra Sánchez, et al.
Published: (2023-10-01)

LP-072 Validity of a claim-based algorithm for SLE disease severity to clinical SLE disease activity index in Korean patients with SLE
by: Sun-Young Jung, et al.
Published: (2023-07-01)

SLE and alpha-SLE driven by Levy processes
by: Guan, Q, et al.
Published: (2008)

LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis
by: Richard Furie, et al.
Published: (2024-03-01)

ADE and SLE
by: Cardy, J
Published: (2007)

01 SLE burden of disease: the patient’s perspective
by: Jeanette Andersen
Published: (2023-09-01)

04 Biologic disease modifying drugs in SLE
by: Maria Dall’Era
Published: (2023-09-01)

Harmonic measure and SLE
by: Beliaev, D, et al.
Published: (2008)

ON THE REGULARITY OF SLE TRACE
by: PETER K. FRIZ, et al.
Published: (2017-01-01)

31 Infections in SLE
by: Sandra Navarra
Published: (2022-04-01)

SLE for theoretical physicists
by: Cardy, J
Published: (2005)

P165 Kinetics of mucocutaneous and musculoskeletal responses to deucravacitinib in patients with systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial
by: Joseph F Merola, et al.
Published: (2024-03-01)

O21 Is SLE-DAS better than BILAG-2004 to identify severe SLE disease activity? Post-hoc analysis of 438 SLE patients from the anifrolumab clinical trials
by: Andrea Doria, et al.
Published: (2024-03-01)

Psychiatric disorders in systemic lupus erythematosus (SLE): a serious SLE-related crime
by: Gabriele Nicolosi, et al.
Published: (2013-04-01)

LP-069 Update of the epidemiology and mortality of juvenile onset SLE and pediatric SLE in Italy
by: Andrea Doria, et al.
Published: (2023-07-01)

PO.2.51 Hyperferritinaemia and systemic disease : SLE or still’s disease?
by: N Bouziani, et al.
Published: (2022-10-01)

11 What is happening in the world of publishing?
by: Ronald van Vollenhoven
Published: (2023-09-01)

I17 Choosing wisely: which biological should we use in which patient?
by: Ronald van Vollenhoven
Published: (2024-03-01)

04 The matter of the debate: LLDAS is an excellent outcome measure, but does it really capture patients with true LDA?
by: Ronald van Vollenhoven
Published: (2022-04-01)

Hidup Diteruskan Dengan SLE
by: Mingguan Malaysia, Shamsiah Zulkifli
Published: (2008)

Perjuangan pesakit SLE kronik
by: Hassan, Najibah
Published: (2024)

16 Management of neuropsychiatric SLE
by: Dimitrios Boumpas
Published: (2022-04-01)

PO.3.62 Cardiopulmonary disease in SLE- increasing trend!
by: S Balasubramanian, et al.
Published: (2022-10-01)

PO.4.75 The anti-BDCA2 antibody biib059 improves joint and skin manifestations in patients with SLE and both active arthritis and rash
by: X Huang, et al.
Published: (2022-10-01)

P118 Increased atherothrombotic risk in SLE patients: the role of oxidative stress in fibrinogen structural and functional modifications
by: Augusto Vaglio, et al.
Published: (2024-03-01)

P58 Menopausal age and the effect of menopause on disease activity in SLE
by: Aleksandra Antovic, et al.
Published: (2024-03-01)

Subclinical pleuro-pulmonary disease in patients with SLE: functional and radiological methods
by: Hanaa S. Hamed, et al.
Published: (2024-02-01)

Sex differences in rheumatoid arthritis: more than meets the eye...
by: van Vollenhoven Ronald F
Published: (2009-03-01)

14 Management of cardiovascular involvement in SLE
by: Bernardo A Pons-Estel
Published: (2023-09-01)

18 Management of musculoskeletal involvement in SLE
by: Andrea Doria
Published: (2023-09-01)

15 Management of cardiovascular involvement in SLE
by: Gerard Espinosa
Published: (2023-09-01)

20 Management of skin involvement in SLE
by: Annegret Kuhn
Published: (2023-09-01)

19 Management of musculoskeletal involvement in SLE
by: José A Gómez-Puerta
Published: (2023-09-01)

21 Management of skin involvement in SLE
by: Antonio Guilabert Vidal
Published: (2023-09-01)

Sains Kesihatan: Gejala SLE Terkawal?
by: Mohd Zain, Rehanah
Published: (2015)

Challenges in the diagnosis and management of SLE in India
by: Rudrarpan Chatterjee, et al.
Published: (2023-12-01)

IFN-γ, should not be ignored in SLE
by: Wenping Liu, et al.
Published: (2022-08-01)

Signatures of Gaussian processes and SLE curves
by: Boedihardjo, H
Published: (2014)

Hydroxychloroquine, TTP, COVID-19, and SLE
by: Pathum Sookaromdee, et al.
Published: (2021-02-01)